Events Archive
Previous Events
RIT Event: "The Organizational Challenge for Energy Technology Innovation"
February 6, 2012
William B. Bonvillian is Director of the Massachusetts Institute of Technology’s Washington, D.C. Office. On February 6, 2012, he presented, "The Organizational Challenge for Energy Technology Innovation" at the Rochester Institute of Technology. This talk detailed attempts to access evolving energy technology policy, focusing on the organizational challenges particularly at the federal government level. For more information, click here.
Process of Discovery Course: Dr. David Valle (Johns Hopkins University School of Medicine) Campus Visit
January 31, 2012
David Valle, MD, PhD, is the Director of the McKusick,-Nathans Institute of Genetic Medicine at Johns Hopkins University School of Medicine. He presented a lecture entitled, "The Quest to Find and Solve All Human Mendelian Disorders: Genomics Meets Genetics," as part of the Process of Discovery course on Tuesday, January 31st. For more information, click here.
Process of Discovery Course: Dr. William Gahl (NIH) Campus Visit
January 30, 2012
William Gahl, MD, PhD, is the Clinical Director of the National Human Genome Research Institute at the National Institutes of Health. He presented a lecture entitled, "The National Institutes of Health - Undiagnosed Diseases Program," as part of the Process of Discovery course on Monday, January 30th, 2012. For more information, click here.
Dr. Kurt Schilling (Johnson & Johnson) Seminar on Leading Edge Trends in Medical Devices and Diagnostics
January 17, 2012
Kurt Schilling, PhD, is currently VP, Assay R&D at Ortho Clinical Diagnostics (OCD) at Johnson & Johnson, where he leads teams in Rochester, NY and Raritan, NJ involved in the development of medical diagnostic assays and platforms. He gave a seminar entitled, "Leading Edge Trends in Medical Devices and Diagnostics: Innovation at Johnson & Johnson Ortho Clinical Diagnostics" on Tuesday, January 17, 2012. This event was sponsored by the Biomedical Engineering Department, the Center for Emerging and Innovative Sciences, and the Office of Research Alliances. For more information, click here.
Dr. Ira Shoulson (Georgetown University) Campus Visit
October 27, 2011
Ira Shoulson, M.D., Professor of Neurology, Pharmacology and Human Science, and Director of the Program for Regulatory Science and Medicine at Georgetown University, gave a presentation entitled, "Regulatory Science and Medicine: It's About Time!" on Thursday, October 27, 2011. The event was co-hosted by the Clinical and Translational Science Institute and the Office of Research Alliances. For more information, click here.
Dr. Allan Goldberg (Merck & Co.) Campus Visit
October 7, 2011
Dr. Allan Goldberg, Executive Director of Academic and Professional Affairs at Merck & Co., gave a presentation entitled, "Preclinical Drug Discovery and Development" on Friday, October 7, 2011. The event was co-hosted by the University Committee for Interdisciplinary Studies in Drug Discovery and the Office of Research Alliances. For more information, click here.
An Overview of Intelligence Advanced Research Projects Activity (IARPA)
September 13, 2011
Dr. Lisa Porter, Director of the Intelligence Advanced Research Projects Activity (IARPA), gave a presentation entitled, "An Overview of IARPA" on Tuesday, September 13th at Rush Rhees Library. For more information about IARPA, click here.
Dr. John D. Obourn (Pfizer) Campus Visit
July 29, 2011
Dr. John D. Obourn, Development Team Head at Pfizer, participated in a special research seminar on Friday, July 29th at the University of Rochester Medical Center. Dr. Obourn's presentation was entitled, "Developing New Medicines: The Process and The Chaos." The seminar was hosted by Richard Phipps, Ph.D., Dean's Professor of Environmental Medicine and Director of the Lung Biology Disease Program, and Scott Steele, Ph.D., Director of the Office of Research Alliances.
Nanomaterials Symposium 2011
May 23, 2011
Frontiers in Materials Science for the 21st Century—Applications in Biomedicine Annual Symposium & Poster Session on Materials Research, sponsored by the UR Chapter of the Materials Research Society.
This full one-day symposium had the overarching theme of innovations in nanometer scale materials science and engineering, necessary to advance biological medicine in the coming decades. Keynote speakers addressed the problem from several perspective, including discussions of photoactive materials, nanometer scale extracellular environments, cell adhesion and signaling, biomimetic materials, and cellular regeneration. Contributed papers discussed biomedical and nanotechnological materials science research at the University of Rochester, as well as in the greater New York area. There was a "Gordon Conference" style format, in which a significant proportion of the conference was reserved for discussion and exchange of ideas.
23rd Annual URMC Genetics Day
May 6, 2011
The 23rd Annual URMC Genetics Day featured presentations by University of Rochester researchers engaged in biomedical and genetics research, a poster session and a keynote lecture by Dr. Keith Yamamoto.
CEIS: University Technology Transfer and Intellectual Property Management
April 21, 2011
A Lecture and Panel Discussion on the Stanford University v. Roche Molecular Systems Case
The Center for Emerging and Innovative Sciences at the University of Rochester presented a lecture and panel discussion on the implications of the Stanford University v. Roche Molecular Systems case. This case, which is now before the U.S. Supreme Court, will attempt to resolve whether an individual inventor may unilaterally terminate a university's right under the Bayh-Dole Act relating to inventions arising from federally funded research. The case has wide ranging implications to universities, individual inventors, and companies licensing or considering licensing technologies from universities and other non-profit organizations.
CTSI Scientific Symposium: Applying Science to Health Care Reform
April 15, 2011
The University of Rochester Clinical and Translational Science Institute (CTSI) hosted an exciting, full-day symposium, entitled, "Applying Science to Health Care Reform." The symposium featured a wide range of presentations, including keynote presentations by Dr. Lawrence Tabak, Deputy Director of the National Institutes of Health (NIH), and Dr. Brian Mittman, Director of the Veterans Affairs (VA) Center for Implementation Practice and Research Support.
CTSB Opening Celebration
April 8, 2011
The University of Rochester Medical Center's new Clinical and Translational Building (CTSB) is the centerpiece of the CTSI's efforts to infuse fresh treatment and prevention insights into everyday patient care. This 200,000 square foot facility was funded, in large part, with $50 million in capital support from New York State. As one of the first buildings of its kind in the United States, the Clinical and Translational Science Building makes URMC a leader in applying biomedical research to improve not only our region's health, but also its economic vitality.
2011 CEIS University Technology Showcase
April 6, 2011
The Center for Emerging and Innovative Sciences (CEIS)* held its annual Technology Showcase on Wednesday, April 6th from 1pm to 6pm at the Doubletree Hotel in Rochester, NY. The theme for this year’s event was “Building an Innovation Economy in New York State." The Showcase provided a forum for participants from the business, academic, and government communities to learn about exciting new university research and technology, and to network with each other.
Dr. Jane Silverthorne (NSF) Campus Visit
February 15, 2011
Dr. Jane Silverthorne is the Deputy Division Director for Integrative Organismal Systems in the Directorate for Biological Sciences at the National Science Foundation. During her lecture, she provided a broad overview of current initiatives and activities at the NSF.
Biomarkers in Translational Research Symposium
October 28-29, 2010
The Biomarkers and Biorepositories in Translational Research Symposium was held at the University of Rochester School of Medicine and Dentistry on October 28-29, 2010. The Symposium explored current opportunities and challenges in biomarker development and biobanking to address several disease areas. Various models of public-private partnerships designed to speed discovery and translational research were also discussed.
The event was co-sponsored by the Clinical and Translational Science Institute (CTSI) and the Office of Research Alliances (ORA).
Energy Research Symposium
October 11, 2010
Energy for the 21st Century 2010 was the second symposium sponsored by the University of Rochester’s Energy Research Initiative. Distinguished speakers from industry, government laboratories and academia shared their vision and were available for interactions. Scientists and engineers from the University of Rochester presented their research in talks and posters, and were available for discussions. Small and large companies will also had the opportunity to exhibit their products and services throughout the day.
Seminar: Sustainable Ecosystem Nanotechnologies
April 13, 2010
John F. Elter, Ph.D., is the Empire Innovation Professor of Nanoengineering and the
Executive Director of the Center for Sustainable Ecosystem Nanotechnologies at the
College of Nanoscale Science and Engineering at SUNY Albany.
The Center for Sustainable Ecosystem Nanotechnologies at the College of Nanoscale Science and Engineering at SUNY Albany is a new organization whose mission is to apply nanotechnology to enable sustainable development. The seminar included an overview of the range of current research activities within the Center, as well a discussion of the unique opportunities for potential collaboration.
The seminar was sponsored by the Energy Research Initiative and the Office of Research Alliances.
Genomics and Translational Medicine Symposium
October 22-23, 2009
The Genomics and Translational Medicine Symposium was held at the University of Rochester on October 22-23, 2009. The Symposium focused on topics in genomics and medicine, and included speakers from academia, government, and the private sector. The meeting was designed to explore the promise and challenges associated with personalized medicine, building on the University’s NIH Clinical and Translational Science Award and the recently established Clinical and Translational Science Institute at the University of Rochester.
